A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

NCT04153929 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

413

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: BI 456906
DRUG: Placebo
DRUG: Semaglutide

Sponsor

Boehringer Ingelheim